Emiliia Bigaeva, MSc

Search results

• 2017

  PI3K/MTOR PATHWAY INHIBITION IN EX-VIVO LIVER MODEL

  Gore, E., Bigaeva, E., Boersema, M., Nicklin, P., Schuppan, D. & Olinga, P., Apr-2017, In: Gastroenterology. 152, 5, p. S1105-S1105 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2016

  Dissecting the molecular antifibrotic effect of the TGF-Beta(I) receptor kinase inhibitor galunisertib in precision-cut liver slices

  Luangmonkong, T., Suriguga, S., Bigaeva, E., Oosterhuis, D., de Jong, K., Schuppan, D., Mutsaers, H. & Olinga, P., 2016, In: Journal of Hepatology. 64, p. S713-S714 2 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

• LPS aggravates fibrosis only in the early onset but not in the end stage of liver fibrosis

  Suriguga, S., Luangmonkong, T., Bigaeva, E., Oosterhuis, D., Mutsaers, H. A., Groothuis, G. M. & Olinga, P., 1-Oct-2016, In: Hepatology. 64, S1, p. 840A

  Research output: Contribution to journal › Meeting Abstract › Academic

  Open Access

  File
  246 Downloads (Pure)